Found 132 matching trials
Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
PHASE3ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis
N/AThe FDA approved the antiviral drug remdesivir for use in adults for the tr...
Location
Semmelweis University - Department of Internal Medicine and Oncology
Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection
PHASE2To study the efficacy and safety of icatibant in adult patients admitted to...
Location
Hospital Universitari de Bellvitge
ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
PHASE2This is a platform trial to conduct a series of randomized, double-blind, p...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
AGILE (Early Phase Platform Trial for COVID-19)
PHASE1The AGILE platform master protocol allows incorporation of a range of ident...
Location
Desmond Tutu Health Foundation
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
PHASE2The (World Health Organization) WHO NOR- (Coronavirus infectious disease) C...
Location
Andreas Barratt-Due
Remdesivir Efficacy in Coronavirus Disease
PHASE2COVID 19 treatment using Remedesvir....
Location
Tanta university hospital, Assuit University, Ainshams University
REMdesivir-HU Clinical Study and Severe Covid-19 Patients
PHASE3This is a Phase 3, open-label, multi-center, interventional safety study of...
Location
Department of Pulmonology Semmelweis University
Adaptive COVID-19 Treatment Trial (ACTT)
PHASE3This study is an adaptive, randomized, double-blind, placebo-controlled tri...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.
PHASE2A randomized, open-label, multicenter, three-arm clinical trial to study th...
Location
LifeFactors Zona Franca SAS